QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2022     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文 CANCER MEDICINE, 2022 作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan 收藏  |  浏览/下载：20/0  |  提交时间：2022/12/23 EGFR-TKIs  non-small cell lung cancer (NSCLC)  real-world study  survival outcome   Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review 期刊论文 JOURNAL OF ONCOLOGY, 2022, 卷号: 2022 作者:  Hu, Shumin;  Gong, Jiali;  Zhu, Xiu;  Lu, Hongyang 收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23 Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1 期刊论文 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Wang, Zuo-wei;  Zou, Feng-ming;  Wang, Ao-li;  Yang, Jing;  Jin, Rui 收藏  |  浏览/下载：20/0  |  提交时间：2022/12/22 AZD4547  RIPK1  inhibitors  SIRS model  anti-necroptosis   Protein disulfide isomerase blocks the interaction of LC3II-PHB2 and promotes mTOR signaling to regulate autophagy and radio/chemo-sensitivity 期刊论文 CELL DEATH & DISEASE, 2022, 卷号: 13 作者:  Wang, Ruru;  Shang, Yajing;  Chen, Bin;  Xu, Feng;  Zhang, Jie 收藏  |  浏览/下载：17/0  |  提交时间：2022/12/22 Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文 FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13 作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang 收藏  |  浏览/下载：17/0  |  提交时间：2022/12/22 HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies   Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 期刊论文 TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 页码: 23 作者:  He, Bing-Xi;  Zhong, Yi-Fan;  Zhu, Yong-Bei;  Deng, Jia-Jun;  Fang, Meng-Jie 收藏  |  浏览/下载：31/0  |  提交时间：2022/06/10 Tumor biomarkers  immunotherapy  lung neoplasms  programmed cell death 1 receptor (PD-1 receptor)  biostatistics   Peptidic microarchitecture-trapped tumor vaccine combined with immune checkpoint inhibitor or PI3K gamma inhibitor can enhance immunogenicity and eradicate tumors 期刊论文 JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 卷号: 10, 期号: 2, 页码: 13 作者:  Du, Yang;  Liu, Ye;  Wang, Di;  Bai, Hua;  Wang, Zhijie 收藏  |  浏览/下载：26/0  |  提交时间：2022/06/06 immunotherapy  immunogenicity  vaccine  tumor microenvironment  lymphocytes  tumor infiltrating  macrophages